Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "author" (Primož Strojan) .

21 - 30 / 116
First pagePrevious page12345678910Next pageLast page
21.
Cysteine proteinase inhibitors stefin A and stefin B in operable carcinoma of the head and neck : Inhibitorji cisteinskih proteinaz stefin A in stefin B pri operabilnem karcinomu glave in vratu
Primož Strojan, Marjan Budihna, Alojz Šmid, Branka Svetic, Ivan Vrhovec, Janko Kos, Janez Škrk, 2002, original scientific article

Abstract: Purpose. To evaluate the significance of cysteine proteinase inhibitors stefins (Stefs) A and B for a treatment decision and prognosis in operable squamous cell carcinoma of the head and neck (SCCHN). Patients and methods. Stefs A and B concentrations were determined immunobiochemically using ELISAs in cytosols prepared from the tumor and adjacent normal mucosa from 91 patients with operable SCCHN. The median follow-up period of patients alive atthe close-out date was 5.8 years (range, 5-9.3 years). Results. Stef A concentrations were significantly higher in tumor compared to normal mucosa (FM.05). When a subgroup with clinically palpable nodes) at presentation was taken into consideration (n=57), a significant difference in Stef A (P=0.03) and Stef B (P=0.02) concentrations between those with negative and positive necks, as determined on histopathological examination, was observed. On the univariate survival analysis, higher Stefsć concentrations turned to be prognostically advantageous. Stef A proved its independent prognostic significance also on multivariate setting. Conclusions. With the capability todifferentiate between the pN0- and pN+-stages of the disease in the patientsoriginally presented as node-positive, Stefs A and B could be useful markers when deciding on the extent of neck surgery. In addition, both Stefs proved to be reliable prognosticators for survival in patients with operable SCCHN.
Published in DiRROS: 31.01.2024; Views: 252; Downloads: 61
.pdf Full text (114,91 KB)

22.
Extramedullary plasmacytoma of the larynx : a report of three cases
Primož Strojan, 2002, other scientific articles

Abstract: Purpose. To report three cases of extramedullary plasmacytoma of the larynx treated at the Institute of Oncology in Ljubljana between 1969-1999. Results. All three patients were treated with radiotherapy only, whieh resulted in permanent local and regional control of 7.8, 4.7 and 3.5 years. The funetion of the larynx was preserved in all of them. Two patients died, both to the causes other than plasmacytoma. In none of the patients disease progressed to multiple rnyeloma. Conclusions. Extramedullary plasmacytoma of the larynx is arare disease, highly curable when radiotherapy is used. Moderate radiation doses and limited fields ensure excellent cosmetic and funetional result.
Published in DiRROS: 31.01.2024; Views: 239; Downloads: 80
.pdf Full text (74,68 KB)

23.
Cathepsin H in squamous cell carcinoma of the head and neck
Primož Strojan, Marjan Budihna, Alojz Šmid, Branka Svetic, Ivan Vrhovec, Janko Kos, Janez Škrk, 1999, original scientific article

Published in DiRROS: 22.01.2024; Views: 288; Downloads: 83
.pdf Full text (557,02 KB)

24.
Three-layer template for low-dose-rate remote afterload transperineal interstitial brachytherapy
Janez Kuhelj, Primož Strojan, Janez Burger, 1997, original scientific article

Published in DiRROS: 17.01.2024; Views: 299; Downloads: 78
.pdf Full text (131,28 KB)

25.
Cathepsins and their endogenous inhibitors in clinical oncology
Primož Strojan, 1996, review article

Published in DiRROS: 16.01.2024; Views: 330; Downloads: 77
.pdf Full text (900,58 KB)

26.
Risk for recurrence of intracranial germinoma
Primož Strojan, Mara Popović, Gabrijela Petrič-Grabnar, Nežika Župančič, Berta Jereb, 1996, original scientific article

Published in DiRROS: 16.01.2024; Views: 279; Downloads: 82
.pdf Full text (626,83 KB)

27.
Odkrivanje in zdravljenje melanoma
Marko Snoj, Janja Ocvirk, Primož Strojan, 2007, preface, editorial, afterword

Published in DiRROS: 06.12.2023; Views: 287; Downloads: 88
.pdf Full text (32,79 KB)

28.
Mesto radioterapije v zdravljenju melanoma
Primož Strojan, 2007, published professional conference contribution

Published in DiRROS: 06.12.2023; Views: 294; Downloads: 83
.pdf Full text (942,67 KB)

29.
In memoriam : prof. dr. Zvonimir Rudolf, dr. med. 1949 – 2023
Jasna But-Hadžić, Primož Strojan, 2023, other component parts

Keywords: medicina, onkologija, biografije
Published in DiRROS: 27.07.2023; Views: 490; Downloads: 113
.pdf Full text (60,95 KB)

30.
Sproščanje dejavnikov imunogene celične smrti HMGB1 in ATP iz celičnih linij se povečuje s časom po obsevanju
Urša Kešar, Tanja Jesenko, Boštjan Markelc, Katja Uršič Valentinuzzi, Maja Čemažar, Primož Strojan, Gregor Serša, 2023, published scientific conference contribution abstract

Keywords: miši, obsevanje, radioterapija
Published in DiRROS: 19.06.2023; Views: 461; Downloads: 202
.pdf Full text (432,50 KB)
This document has many files! More...

Search done in 1.18 sec.
Back to top